[CrossRef] 14. Schmidt, J.; Smith, A.R.; Magnin, M.; Racle, J.; Devlin, J.R.; Bobisse, S.; Cesbron, J.; Bonnet, V .; Carmona, S.J.; Huber, F.; et al. Prediction of Neo-Epitope Immunogenicity Reveals TCR Recognition Determinants and Provides Insight into Immunoediting. Cell Rep. Med. 2021 ,2, 100194. [CrossRef] 15. Wells, D.K.; van Buuren, M.M.; Dang, K.K.; Hubbard-Lucey, V .M.; Sheehan, K.C.F.; Campbell, K.M.; Lamb, A.; Ward, J.P .; Sidney, J.; Blazquez, A.B.; et al. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction. Cell2020 ,183, 818–834.e13. [CrossRef] 16. Kumar, H.; Luo, R.; Wen, J.; Yang, C.; Zhou, X.; Kim, P . FusionNeoAntigen: A Resource of Fusion Gene-Specific Neoantigens. Nucleic Acids Res. 2024 ,52, D1276–D1288. [CrossRef] 17. Greaves, M. A Causal Mechanism for Childhood Acute Lymphoblastic Leukaemia. Nat. Rev. Cancer 2018 ,18, 471–484. [CrossRef] 18. Schram, A.M.; Chang, M.T.; Jonsson, P .; Drilon, A. Fusions in Solid Tumours: Diagnostic Strategies, Targeted Therapy, and Acquired Resistance. Nat. Rev. Clin. Oncol. 2017 ,14, 735–748. [CrossRef] 19. Dai, X.; Theobard, R.; Cheng, H.; Xing, M.; Zhang, J. Fusion Genes: A Promising Tool Combating against Cancer. Biochim.